GL1X · GenesisL1 explorer

Research workbench

CLK1 with bound pyridoquinazoline

Analyse CLK1 with bound pyridoquinazoline in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6Q8K
Type
protein
Length
338 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity protein kinase CLK1
EC
2.7.12.1
UniProt
P49759
Ligands
FG9
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity protein kinase CLK1 (EC 2.7.12.1)protein33841% helix, 20% strandP49759

Ligands and binding sites

  • FG9 · ~{N}2-(3-morpholin-4-ylpropyl)pyrido[3,4-g]quinazoline-2,10-diamine · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14570.700.8049FG9

Compared structures

  • 6Q8K · CLK1 with bound pyridoquinazoline · the same entry in another collection · chain A against A, TM-score 1.00
  • P49759 · AlphaFold monomer V2.0 prediction for dual specificity protein kinase CLK1 (P49759) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.